GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

This study has been terminated.

( The development program has been terminated )

Study NCT00300105 Information provided by AstraZeneca

First Received: March 7, 2006 Last Updated: March 14, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given